Publication:
Iatrogenic hyperviscosity and thrombosis

dc.contributor.coauthorMeiselman, Herbert J.
dc.contributor.kuauthorBaşkurt, Oğuz Kerim
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid2389
dc.date.accessioned2024-11-09T13:45:33Z
dc.date.issued2012
dc.description.abstractIt is well known that hemostatic-thrombotic mechanisms are influenced by hemodynamic factors, such as shear forces affecting platelets or red blood cell aggregation, in turn affecting flow in stenotic regions. Endothelial cell function is also significantly influenced by shear forces acting on the vessel wall. Further, the distribution of shear forces in the vasculature is complex and closely associated with factors determining the flow properties of blood. Therefore, there is a link among alterations in the rheological properties of blood and its elements and the risk for thrombosis, with this linkage confirmed by numerous clinical studies. After discussing relevant rheological and hemodynamic concepts, this review focuses on selected drug-induced conditions that are known to be associated with both hyperviscosity conditions and increased thrombotic risk: oral contraceptives, diuretics, intravenous immunoglobulin, erythropoiesis-stimulating agents, chemotherapy, and radio-contrast media. Alterations of relationships between blood rheology and thrombotic risk related to artificial circulatory environments and physical exercise are also briefly discussed.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue8
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume38
dc.formatpdf
dc.identifier.doi10.1055/s-0032-1325616
dc.identifier.eissn1098-9064
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR00200
dc.identifier.issn0094-6176
dc.identifier.linkhttps://doi.org/10.1055/s-0032-1325616
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-84868586142
dc.identifier.urihttps://hdl.handle.net/20.500.14288/3628
dc.identifier.wos310783600013
dc.keywordsCardiovascular system
dc.keywordsBlood rheology
dc.keywordsErythrocyte deformability
dc.keywordsErythrocyte aggregation
dc.keywordsHemodynamics
dc.keywordsCoagulation
dc.keywordsBlood-cell aggregation
dc.keywordsRecombinant-human-erythropoietin
dc.keywordsDose intravenous immunoglobulin
dc.keywordsFemale hypertensive patients
dc.keywordsVon-willebrand-factor
dc.keywordsWall shear-stress
dc.keywordsPolycythemia-vera
dc.keywordsContrast-media
dc.keywordsOral-contraceptives
dc.keywordsPlasma viscosity
dc.languageEnglish
dc.publisherThieme Publishing
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/1228
dc.sourceSeminars in Thrombosis and Hemostasis
dc.subjectMedicine
dc.subjectHematology
dc.subjectCardiology
dc.titleIatrogenic hyperviscosity and thrombosis
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorBaşkurt, Oğuz Kerim

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
1228.pdf
Size:
181.21 KB
Format:
Adobe Portable Document Format